These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35274134)

  • 1. Stress ulcer prophylaxis in the cardiac surgery intensive care unit.
    Glaser N; Sartipy U
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35274134
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
    van Diepen S; Coulson T; Wang X; Opgenorth D; Zuege DJ; Harris J; Agyemang M; Niven DJ; Bellomo R; Wright SE; Young PJ; Bagshaw SM;
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35213716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
    Zhou JF; Wan XY; Huang W; Han LL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for the Use of Proton Pump Inhibitors for Stress Ulcer Prophylaxis and Peptic Ulcer Bleeding in Hospitalized Patients.
    Clarke K; Adler N; Agrawal D; Bhakta D; Sata SS; Singh S; Gupta A; Pahwa A; Pherson E; Sun A; Volpicelli F; Cho HJ
    Am J Med; 2022 Mar; 135(3):313-317. PubMed ID: 34655535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stress ulcer prophylaxis with proton pump inhibitors in intensive care medicine].
    Kasper P; Tacke F; Michels G
    Med Klin Intensivmed Notfmed; 2024 Oct; 119(7):598-599. PubMed ID: 39120611
    [No Abstract]   [Full Text] [Related]  

  • 6. Stress Ulcer Prophylaxis: Who, When, and Why Stress Out About It?
    Larson A; Ahrndt S; Jansen T
    S D Med; 2016 Apr; 69(4):176-7. PubMed ID: 27263167
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    ; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
    JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Question: Should gastric protection with a histamine2-receptor blocker or a proton pump inhibitor be ordered for stress ulcer prophylaxis on virtually every adult patient admitted to the hospital for something other than elective surgery?
    Hopkins L; Stockert K; Coyner C; Palmer P
    J Okla State Med Assoc; 2011 Mar; 104(3):85-6. PubMed ID: 21608449
    [No Abstract]   [Full Text] [Related]  

  • 9. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
    Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
    Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress ulcer prophylaxis: friend or foe?
    Macdonald JJ; Roberts JC; Washington S
    Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209
    [No Abstract]   [Full Text] [Related]  

  • 11. The implications of the PEPTIC trial for clinical practice.
    Young PJ; Bagshaw SM; Bellomo R; Nichol AD; Wright SE
    Crit Care Resusc; 2020 Mar; 22(1):4-5. PubMed ID: 32102637
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
    Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
    J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
    Krag M; Perner A; Wetterslev J; Møller MH
    Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and economic benefits of de-escalating stress ulcer prophylaxis therapy in the intensive care unit: A quality improvement study.
    Anstey MH; Litton E; Palmer RN; Neppalli S; Tan BJ; Hawkins DJ; Krishnamurthy RB; Jacques A; Sonawane RV; Chapman AR; Norman R
    Anaesth Intensive Care; 2019 Nov; 47(6):503-509. PubMed ID: 31594383
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis.
    Yao DWJ; Ong C; Eales NM; Sultana R; Wong JJ; Lee JH
    J Pediatr; 2021 Jan; 228():164-176.e7. PubMed ID: 32916144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress ulcer prophylaxis in ICU patients: Answers and questions from the PEPTIC trial.
    Dargent A; Jacquier M; Rozencwajg S; Andreu P; Quenot JP
    Anaesth Crit Care Pain Med; 2020 Apr; 39(2):175-177. PubMed ID: 32147580
    [No Abstract]   [Full Text] [Related]  

  • 18. Stress ulcer prophylaxis in adult intensive care unit patients - a protocol for a systematic review.
    Barbateskovic M; Marker S; Jakobsen JC; Krag M; Granholm A; Anthon CT; Perner A; Wetterslev J; Møller MH
    Acta Anaesthesiol Scand; 2018 Jul; 62(6):744-755. PubMed ID: 29577238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
    Boyd C; Hassig T; MacLaren R
    Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of an electronic medical record-based alarm in the optimization of stress ulcer prophylaxis.
    Saad EJ; Bedini M; Becerra AF; Martini GD; Gonzalez JG; Bolomo A; Castellani L; Quiroga S; Morales C; Leathers J; Balderramo D; Albertini RA
    Gastroenterol Hepatol; 2018; 41(7):432-439. PubMed ID: 29895412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.